CRSP
Price
$70.16
Change
-$0.81 (-1.14%)
Updated
Mar 27, 6:59 PM EST
33 days until earnings call
INMB
Price
$11.65
Change
+$0.02 (+0.17%)
Updated
Mar 28, 11:53 AM EST
Earnings call today
Ad is loading...

Compare predictions CRSP vs INMB

Header iconCRSP vs INMB Comparison
Open Charts CRSP vs INMBBanner chart's image
CRISPR Therapeutics AG
Price$70.16
Change-$0.81 (-1.14%)
Volume$714.13K
CapitalizationN/A
INmune Bio
Price$11.65
Change+$0.02 (+0.17%)
Volume$1K
CapitalizationN/A
View a ticker or compare two or three
CRSP vs INMB Comparison Chart

Loading...

CRSPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CRSP vs. INMB commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and INMB is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (CRSP: $70.16 vs. INMB: $11.66)
Brand notoriety: CRSP and INMB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 70% vs. INMB: 121%
Market capitalization -- CRSP: $5.63B vs. INMB: $210.13M
CRSP [@Biotechnology] is valued at $5.63B. INMB’s [@Biotechnology] market capitalization is $210.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileINMB’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • INMB’s FA Score: 0 green, 5 red.
According to our system of comparison, CRSP is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 1 TA indicator(s) are bullish while INMB’s TA Score has 3 bullish TA indicator(s).

  • CRSP’s TA Score: 1 bullish, 7 bearish.
  • INMB’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, INMB is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а -3.81% price change this week, while INMB (@Biotechnology) price change was +0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +5.11%, and the average quarterly price growth was +88.96%.

Reported Earning Dates

CRSP is expected to report earnings on Apr 30, 2024.

INMB is expected to report earnings on May 01, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRSP with price predictions.
OPEN
A.I.dvisor published
a Summary for INMB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRSP($5.63B) has a higher market cap than INMB($210M). CRSP YTD gains are higher at: 12.077 vs. INMB (3.552). INMB has higher annual earnings (EBITDA): -27M vs. CRSP (-202.7M). CRSP has more cash in the bank: 1.69B vs. INMB (41.8M). INMB has less debt than CRSP: INMB (12.9M) vs CRSP (239M). CRSP has higher revenues than INMB: CRSP (370M) vs INMB (224K).
CRSPINMBCRSP / INMB
Capitalization5.63B210M2,682%
EBITDA-202.7M-27M751%
Gain YTD12.0773.552340%
P/E Ratio20.92N/A-
Revenue370M224K165,179%
Total Cash1.69B41.8M4,053%
Total Debt239M12.9M1,853%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPINMB
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
CRSPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SZCAX45.600.78
+1.74%
DWS Small Cap Core A
SLVRX32.000.50
+1.59%
Columbia Select Large Cap Value R
RTIRX10.830.07
+0.65%
Russell Inv Multifactor Intl Eq R6
HJIGX11.560.04
+0.35%
Hardman Johnston Intl Gr Fd Instl Shr
JHQRX29.890.01
+0.03%
JPMorgan Hedged Equity R6

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been loosely correlated with SANA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRSP jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.14%
SANA - CRSP
59%
Loosely correlated
+5.71%
AGIO - CRSP
54%
Loosely correlated
+0.34%
SGMO - CRSP
52%
Loosely correlated
+3.53%
AXON - CRSP
49%
Loosely correlated
-1.13%
AGEN - CRSP
49%
Loosely correlated
+3.73%
More